Kyu-Yeon Jun

757 total citations
20 papers, 638 citations indexed

About

Kyu-Yeon Jun is a scholar working on Molecular Biology, Toxicology and Organic Chemistry. According to data from OpenAlex, Kyu-Yeon Jun has authored 20 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Toxicology and 7 papers in Organic Chemistry. Recurrent topics in Kyu-Yeon Jun's work include Cancer therapeutics and mechanisms (11 papers), Bioactive Compounds and Antitumor Agents (9 papers) and Synthesis and biological activity (7 papers). Kyu-Yeon Jun is often cited by papers focused on Cancer therapeutics and mechanisms (11 papers), Bioactive Compounds and Antitumor Agents (9 papers) and Synthesis and biological activity (7 papers). Kyu-Yeon Jun collaborates with scholars based in South Korea, United States and Egypt. Kyu-Yeon Jun's co-authors include Youngjoo Kwon, Eung-Seok Lee, Younghwa Na, Tara Man Kadayat, Chanmi Park, Radha Karki, Kyung-Hwa Jeon, Til Bahadur Thapa Magar, Ganesh Bist and Soeun Park and has published in prestigious journals such as Journal of Medicinal Chemistry, Cell Host & Microbe and Cancer Letters.

In The Last Decade

Kyu-Yeon Jun

20 papers receiving 634 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kyu-Yeon Jun South Korea 17 360 262 123 86 62 20 638
Subhasis Banerjee India 18 391 1.1× 301 1.1× 20 0.2× 153 1.8× 22 0.4× 63 1.0k
Y. Makino Japan 14 463 1.3× 88 0.3× 24 0.2× 24 0.3× 11 0.2× 39 669
Morten O. Christensen Germany 16 833 2.3× 80 0.3× 101 0.8× 191 2.2× 55 0.9× 24 1.0k
Toshihiro Imaeda Japan 11 334 0.9× 138 0.5× 8 0.1× 29 0.3× 32 0.5× 20 597
Dong Jae Baek South Korea 16 607 1.7× 311 1.2× 15 0.1× 49 0.6× 55 0.9× 51 1.1k
Stanley J. Schmidt United States 12 323 0.9× 193 0.7× 16 0.1× 62 0.7× 53 0.9× 21 546
Ángel Amesty Spain 13 197 0.5× 207 0.8× 72 0.6× 35 0.4× 59 1.0× 40 464
Phillip C.C. Liu United States 14 612 1.7× 70 0.3× 41 0.3× 50 0.6× 21 0.3× 22 750
Ryszard Szyszka Poland 19 700 1.9× 110 0.4× 18 0.1× 77 0.9× 53 0.9× 47 891
Graeme Thomson United Kingdom 12 380 1.1× 82 0.3× 14 0.1× 54 0.6× 27 0.4× 21 538

Countries citing papers authored by Kyu-Yeon Jun

Since Specialization
Citations

This map shows the geographic impact of Kyu-Yeon Jun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyu-Yeon Jun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyu-Yeon Jun more than expected).

Fields of papers citing papers by Kyu-Yeon Jun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyu-Yeon Jun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyu-Yeon Jun. The network helps show where Kyu-Yeon Jun may publish in the future.

Co-authorship network of co-authors of Kyu-Yeon Jun

This figure shows the co-authorship network connecting the top 25 collaborators of Kyu-Yeon Jun. A scholar is included among the top collaborators of Kyu-Yeon Jun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyu-Yeon Jun. Kyu-Yeon Jun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Eun Kyoung, Kyung-Ah Lee, Do Young Hyeon, et al.. (2020). Bacterial Nucleoside Catabolism Controls Quorum Sensing and Commensal-to-Pathogen Transition in the Drosophila Gut. Cell Host & Microbe. 27(3). 345–357.e6. 43 indexed citations
2.
3.
Karki, Radha, Kyu-Yeon Jun, Tara Man Kadayat, et al.. (2016). A new series of 2-phenol-4-aryl-6-chlorophenyl pyridine derivatives as dual topoisomerase I/II inhibitors: Synthesis, biological evaluation and 3D-QSAR study. European Journal of Medicinal Chemistry. 113. 228–245. 22 indexed citations
4.
Kadayat, Tara Man, Seojeong Park, Kyu-Yeon Jun, et al.. (2016). Effect of chlorine substituent on cytotoxic activities: Design and synthesis of systematically modified 2,4-diphenyl-5H-indeno[1,2-b]pyridines. Bioorganic & Medicinal Chemistry Letters. 26(7). 1726–1731. 19 indexed citations
7.
Jun, Kyu-Yeon & Youngjoo Kwon. (2016). Proposal of Dual Inhibitor Targeting ATPase Domains of Topoisomerase II and Heat Shock Protein 90. Biomolecules & Therapeutics. 24(5). 453–468. 19 indexed citations
8.
Jun, Kyu-Yeon, Tara Man Kadayat, Chanmi Park, et al.. (2015). Design and synthesis of conformationally constrained hydroxylated 4-phenyl-2-aryl chromenopyridines as novel and selective topoisomerase II-targeted antiproliferative agents. Bioorganic & Medicinal Chemistry. 23(19). 6454–6466. 27 indexed citations
9.
Park, Chanmi, Kyung-Hwa Jeon, Eun‐Young Lee, et al.. (2015). A Series of Novel Terpyridine-Skeleton Molecule Derivants Inhibit Tumor Growth and Metastasis by Targeting Topoisomerases. Journal of Medicinal Chemistry. 58(3). 1100–1122. 97 indexed citations
10.
Kadayat, Tara Man, Chanmi Park, Kyu-Yeon Jun, et al.. (2014). Hydroxylated 2,4-diphenyl indenopyridine derivatives as a selective non-intercalative topoisomerase IIα catalytic inhibitor. European Journal of Medicinal Chemistry. 90. 302–314. 32 indexed citations
11.
Karki, Radha, Chanmi Park, Kyu-Yeon Jun, et al.. (2014). Synthesis, antitumor activity, and structure–activity relationship study of trihydroxylated 2,4,6-triphenyl pyridines as potent and selective topoisomerase II inhibitors. European Journal of Medicinal Chemistry. 84. 555–565. 33 indexed citations
12.
Jin, Cheng‐Hao, Kyu-Yeon Jun, Eunjung Lee, et al.. (2014). Ethyl 2-(benzylidene)-7-methyl-3-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidine-6-carboxylate analogues as a new scaffold for protein kinase casein kinase 2 inhibitor. Bioorganic & Medicinal Chemistry. 22(17). 4553–4565. 17 indexed citations
13.
Jun, Kyu-Yeon, Soeun Park, Eun‐Young Lee, et al.. (2014). Discovery of dihydroxylated 2,4-diphenyl-6-thiophen-2-yl-pyridine as a non-intercalative DNA-binding topoisomerase II-specific catalytic inhibitor. European Journal of Medicinal Chemistry. 80. 428–438. 30 indexed citations
14.
Jeon, Kyung-Hwa, Kyu-Yeon Jun, Yeung Bae Jin, et al.. (2013). Dithiiranylmethyloxy azaxanthone shows potent anti-tumor activity via suppression of HER2 expression and HER2-mediated signals in HER2-overexpressing breast cancer cells. European Journal of Pharmaceutical Sciences. 50(2). 181–190. 11 indexed citations
15.
Lee, Eunyoung, Kyu-Yeon Jun, Hwa‐Jung Kim, et al.. (2012). Effect of conjugated linoleic acid, μ-calpain inhibitor, on pathogenesis of Alzheimer's disease. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1831(4). 709–718. 37 indexed citations
16.
Jeon, Kyung-Hwa, Kyu-Yeon Jun, Yongmun Choi, et al.. (2012). A-62176, a potent topoisomerase inhibitor, inhibits the expression of human epidermal growth factor receptor 2. Cancer Letters. 325(1). 72–79. 11 indexed citations
17.
Jun, Kyu-Yeon, Eun Young Lee, Eung-Seok Lee, et al.. (2011). Synthesis, biological evaluation, and molecular docking study of 3-(3′-heteroatom substituted-2′-hydroxy-1′-propyloxy) xanthone analogues as novel topoisomerase IIα catalytic inhibitor. European Journal of Medicinal Chemistry. 46(6). 1964–1971. 48 indexed citations
18.
Choi, Youngsok, Min‐Ho Lee, Miseon Park, et al.. (2010). Mutations in SOHLH1 gene associate with nonobstructive Azoospermia. Human Mutation. 31(7). 788–793. 68 indexed citations
19.
20.
Xia, Youlin, et al.. (2005). IP‐COSY, a totally in‐phase and sensitive COSY experiment. Magnetic Resonance in Chemistry. 43(5). 372–379. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026